Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Double-Blind, Double Dummy, Multicenter Phase 2 Study of the Safety/Tolerability and Efficacy of JNJ-32729463 Compared With Linezolid (Zyvox) for the Treatment of Complicated Skin and Skin Structure Infection

NCT01128530 is registered in ClinicalTrials.gov with Furiex Pharmaceuticals, Inc as lead sponsor.

NCT NCT01128530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Double-Blind, Double Dummy, Multicenter Phase 2 Study of the Safety/Tolerability and Efficacy of JNJ-32729463 Compared With Linezolid (Zyvox) for the Treatment of Complicated Skin and Skin Structure Infection
Lead sponsor
Furiex Pharmaceuticals, Inc
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
January 31, 2011
Enrollment
161 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

complicated skin and skin structure infections